StonvexLoading…
StonvexStonvexStonvexCore line items from ULBI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $191.16M | $164.46M | $158.64M | $131.84M |
Operating Income | $-5.90M | $9.96M | $9.47M | $129.00K |
Net Income | $-5.90M | $6.31M | $7.20M | $-119.00K |
EPS (Diluted) | $-35.00 | $38.00 | $0.44 | $0.05 |
Total Assets | $216.91M | $220.45M | $178.28M | $168.43M |
Total Liabilities | $86.78M | $86.26M | $52.85M | $52.03M |
Cash & Equivalents | $9.35M | $6.85M | $10.20M | $5.63M |
Free Cash Flow OCF − CapEx | $7.12M | $14.70M | $-623.00K | $-2.94M |
Shares Outstanding | 16.66M | 16.63M | 16.35M | 16.35M |